VCYT
Veracyte, Inc.
Stock
$45.81+1.62 (+3.67%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $562M | +34.5% |
| Gross profit | $403M | — |
| Operating income | $106M | — |
| Net income | $114M | — |
| EPS | $1.39 | — |
| Free cash flow | $166M | — |
Veracyte, Inc.
$45.81+1.62 (+3.67%)Close Oct 2, 2026
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $562M | +34.5% |
| Gross profit | $403M | — |
| Operating income | $106M | — |
| Net income | $114M | — |
| EPS | $1.39 | — |
| Free cash flow | $166M | — |